Patent ID: 7256191

Claim:
A method for treating a disease state which can be improved by a serotonin reuptake inhibitor wherein said method comprises administering, to an individual in need of such treatment, a compound, or salt thereof, wherein said compound has the following structure and wherein R 1 and R 2 are independently H or C 1-10 alkyl; or R 1 and R 2 are methylene groups that together form part of a cyclic structure; R 3 is a linear or branched alkyl or heteroalkyl group having 1 to 12 carbon atoms; or R 3 is heterocycloalkyl, benzyl, aryl, or heteroaryl optionally substituted with one or more halogen atoms C 1-4 alkyl, C 1-4 alkoxy, hydroxy, cyano, amino, alkylamino, dialkylamino, trifluoromethyl,— COOH, or —COOC 1-4 alkyl; X is fluoro, chloro, iodo, trifluoromethyl, methoxy, cyano, nitro, amino, mono- or di-substituted amino, carboxamide, carboxylic acid, carboxylic ester, sulfonic acid, methyl sulfonate, or sulfonamide; n is from 0 to 12, and Z=